Therapeutic Advances in Musculoskeletal Disease

Papers
(The TQCC of Therapeutic Advances in Musculoskeletal Disease is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis121
The socioeconomic status of patients with ankylosing spondylitis and its association with the burden of the disease and permanent disability: a cross-sectional cluster analysis65
Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study36
Is there wastage in the research resources for ankylosing spondylitis? An analysis of clinical trial discontinuation and nonpublication outcome35
Actigraphy-derived physical activity levels and circadian rhythm parameters in patients with psoriatic arthritis: relationship with disease activity, mood, age and BMI27
Anti-sclerostin antibodies: a new frontier in fragility fractures treatment26
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data26
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients26
Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients24
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review23
Wearable transcutaneous electrical nerve stimulation (actiTENS®) is effective and safe for the treatment of knee osteoarthritis pain: a randomized controlled trial versus weak opioids22
Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs)22
Reduced bone mineral density in patients with idiopathic inflammatory myopathies: a case-control study20
The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs20
Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry19
Calcineurin inhibitors in systemic sclerosis – a systematic literature review19
Based on minimal clinically important difference values, a moderate dose of tanezumab may be a better option for treating hip or knee osteoarthritis: a meta-analysis of randomized controlled trials17
Health disparities in rheumatoid arthritis17
Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors17
A glimpse into the future of systemic lupus erythematosus16
Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome16
Bone fragility: conceptual framework, therapeutic implications, and COVID-19-related issues16
The association between gout flares and monosodium urate burden assessed using musculoskeletal ultrasound in patients with gout16
Sjögren syndrome: looking forward to the future15
Estimation of fracture risk by the FRAX tool in patients with systemic lupus erythematosus: a 10-year longitudinal validation study15
Future challenges in rheumatology – is telemedicine the solution?15
Stromal vascular fraction therapy for knee osteoarthritis: a systematic review15
Role of imaging for eligibility and safety of a-NGF clinical trials14
Intramuscular methylprednisolone administration in hand osteoarthritis patients: a feasibility study to inform a randomized controlled trial14
Effects of acupuncture versus placebo on clinical status and potential specific effects in Fibromyalgia: an umbrella review of 11 meta-analyses14
Early knee OA definition–what do we know at this stage? An imaging perspective14
T-score discordance between hip and lumbar spine: risk factors and clinical implications14
Real-world evidence to assess the effectiveness of platelet-rich plasma in the treatment of knee degenerative pathology: a prospective observational study14
Gout increases length of stay in patients hospitalized for heart failure exacerbation13
Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA13
An oleuropein-based dietary supplement may improve joint functional capacity in older people with high knee joint pain: findings from a multicentre-RCT and post hoc analysis13
Evaluation of local tissue peri-implant reaction in total knee arthroplasty failure cases13
Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care13
Advanced imaging techniques in crystal arthritis13
Systemic lupus erythematosus is associated with increased risk of Parkinson’s disease13
Magnetic resonance imaging assessments for knee segmentation and their use in combination with machine/deep learning as predictors of early osteoarthritis diagnosis and prognosis13
Mechanisms hypothesized for pain-relieving effects of exercise in fibromyalgia: a scoping review12
A novel infrapatellar approach of ultrasound-guided intra-articular injection of the knee from both lateral and medial side: a case series12
Bone marrow edema in children: chronic nonbacterial osteomyelitis and its mimickers12
MRI lesions in SpA: a comparison with noninflammatory back pain using propensity score adjustment method12
Precision medicine using molecular-target drugs in psoriatic arthritis11
A broad look into the future of rheumatoid arthritis11
The analysis of the pulmonary domain involvement in Sjögren’s disease11
Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs)11
Precision medicine in axial spondyloarthritis: current opportunities and future perspectives11
Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus10
Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucose10
Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy10
Latest insights in disease-modifying osteoarthritis drugs development10
Circulating microRNAs differentiate fast-progressing from slow-progressing and non-progressing knee osteoarthritis in the Osteoarthritis Initiative cohort10
Risk factors associated with the occurrence of total knee arthroplasty in patients with knee osteoarthritis: a nested case–control study10
Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on ‘Diagnosis, risk stratification, and continuity of care of fragility fractures’ based on a systematic10
A glance into the future of myositis therapy9
Measuring sedentary behavior using waist- and thigh-worn accelerometers and inclinometers – are the results comparable?9
SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD9
Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthr9
0.061969995498657